"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year," Mazumdar-Shaw said.
Shaw, 67, founded Bangalore-based Biocon Limited in 1978 with just two employees and currently leads the company that is now worth close to Rs 50,000 crore by market-cap and employs more than 11,000 people.
Shaw added that the focus was needed more on flattening the death curve than the infection curve.
She was speaking in a webinar on 'Pharma and Healthcare's New Normal: Engaging With Customers in Uncertain Times; Business Model Post-COVID-19', organised by CorpGini.
"I think now there is anyway no point in extending the lockdown because of exodus of the migrant labour; they have basically gone to various parts of the country without any controls. So, now there is no point trying to extend lockdown any further. Now, its a question of quickly bringing under control any outbreak," Mazumdar-Shaw said.
Talking about the government's economic stimulus package, Biocon chief Kiran Mazumdar Shaw said that we have lost a big opportunity to create demand.
States with good primary healthcare system have fared better in containing the spread of COVID-19, biotechnology industry veteran Kiran Mazumdar- Shaw said
In an interview to PTI, the Executive Chairperson bio-pharmaceuticals major Biocon Ltd also suggested creating smaller red zones instead of classifying entire district as one so that economic activity picks up and supply chain is not cut-off.
"The seismic events unleashed by the COVID-19 pandemic will have a powerful impact on the world we live in, changing it in ways we had never imagined were possible. The economic damage is likely to be unprecedented," Mazumdar-Shaw said.
The Chairman and Managing Director of Biocon Ltd said she personally believes that schools and colleges - high risk areas where the virus can easily spread -- should be shut till June end.
Mazumdar-Shaw said testing by private labs will plummet, since they are conducting the tests at an upfront cost.
COVID-19 crisis has shown us that we have to focus on these very important healthcare areas. Infectious diseases have been neglected and ignored for too long, Mazumdar-Shaw pointed out.
The government reported 227 fresh cases of infections nation-wide the highest for a day on Monday.
"The government has done the right thing. Scientifically, you need those three weeks," the Chairman and Managing Director of Biocon Ltd, told PTI.
Shaw said that COVID-19 is still under control in India, but we need to be very careful.
When asked about the situation with regards to supply and raw material prices, Mazumdar Shaw said, "If this continues beyond six months, we do have to worry about the impact. For now, we are okay."
Reiterating on the importance of primary healthcare, she said, "It is the starting point for looking at how to basically diagnose early, how to basically create awareness, how to basically immunise people in a community."
Shaw, who had earlier said the government treated India Inc as "pariahs" and doesn't want to hear any criticism of the economy, was responding to Finance Minister Nirmala Sitharman remarks that spreading one's own impression "can hurt national interest" in relation to the statement made by Bajaj on Saturday.
"Hope the govt reaches out to India inc for working out solutions to revive consumption n growth. So far we are all pariahs n govt does not want to hear any criticism of our economy," Shaw said in a tweet.
The Biocon chief also flagged the deepening trust deficit between government and the industry saying there is an increasing tendency to criminalise every businessman.
The Securities and Exchange Board of India (SEBI) had conducted an examination in the matter of Infosys and observed that Mazumdar Shaw had delayed making the requisite disclosures with respect to change in her shareholding in the company.
This comes after the Twitter spat between the Biocon MD and FM Sitharaman a day ago, wherein Shaw had said that it was surprising that the announcement of the ban on e-cigarettes was coming from the finance minister and not the health minister.
Shaw had wondered why Finance Minister, and not the health minister, addressed the press conference on Wednesday to announce a ban on e-cigarettes.
Speaking at the 'India Economic Conclave 2019' in Bengaluru, Shaw said no one expected the GDP growth to be this low, and marked out infrastructure as the key area which the Government should focus on.
According to a regulatory filing by Infosys on results of postal ballot on reappointment of Shaw, 92.2 per cent of the overall votes were cast in favour of the proposal - an outright majority - while nearly 7.7 per cent were against the said resolution.